# Atlanta Braves Holdings, Inc.: financial statements, quarterly

BATRA · Nasdaq · CIK 1958140 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/batra.md) · [Financials](/companies/batra/financials.md) · [Filings](/companies/batra/filings.md) · [Insiders](/companies/batra/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/batra/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [272](/filings/0001558370-24-014717.md) | [67.7 d](/filings/0001104659-26-020650.md) | [37.1](/filings/0001558370-25-007293.md) | [283](/filings/0001558370-25-010754.md) | [291](/filings/0001104659-25-106839.md) | [52.1 d](/filings/0001104659-26-020650.md) | [47.2](/filings/0001104659-26-058558.md) | [312](/filings/0001104659-26-091124.md) | [312](/filings/0001104659-25-106839.md) | [61.3 d](/filings/0001104659-26-020650.md) | [72.0](/filings/0001104659-26-058558.md) | [305](/filings/0001104659-26-091124.md) |
| Selling, general and administrative | $m | [34.4](/filings/0001558370-24-014717.md) | [30.0 d](/filings/0001104659-26-020650.md) | [27.1](/filings/0001558370-25-007293.md) | [33.4](/filings/0001558370-25-010754.md) | [37.1](/filings/0001104659-25-106839.md) | [28.1 d](/filings/0001104659-26-020650.md) | [27.2](/filings/0001104659-26-058558.md) | [34.9](/filings/0001104659-26-091124.md) | [34.8](/filings/0001104659-25-106839.md) | [32.0 d](/filings/0001104659-26-020650.md) | [35.3](/filings/0001104659-26-058558.md) | [43.6](/filings/0001104659-26-091124.md) |
| Operating income | $m | [15.7](/filings/0001558370-24-014717.md) | [(32.4) d](/filings/0001104659-26-020650.md) | [(52.4)](/filings/0001558370-25-007293.md) | [24.9](/filings/0001558370-25-010754.md) | [6.4](/filings/0001104659-25-106839.md) | [(18.6) d](/filings/0001104659-26-020650.md) | [(44.5)](/filings/0001104659-26-058558.md) | [41.8](/filings/0001104659-26-091124.md) | [38.9](/filings/0001104659-25-106839.md) | [(49.8) d](/filings/0001104659-26-020650.md) | [(41.3)](/filings/0001104659-26-058558.md) | [(18.5)](/filings/0001104659-26-091124.md) |
| Interest expense | $m | [9.7](/filings/0001558370-23-017641.md) | [9.7 d](/filings/0001558370-24-002078.md) | [9.4](/filings/0001558370-24-007307.md) | [9.7](/filings/0001558370-25-010754.md) | [9.6](/filings/0001104659-25-106839.md) | [10.1 d](/filings/0001104659-26-020650.md) | [10.3](/filings/0001104659-26-058558.md) | [11.7](/filings/0001104659-26-091124.md) | [12.3](/filings/0001104659-25-106839.md) | [12.2 d](/filings/0001104659-26-020650.md) | [11.2](/filings/0001104659-26-058558.md) | [11.6](/filings/0001104659-26-091124.md) |
| Income tax | $m | [8.3](/filings/0001558370-24-014717.md) | [(6.0) d](/filings/0001104659-26-020650.md) | [(4.2)](/filings/0001558370-25-007293.md) | [0.9](/filings/0001558370-25-010754.md) | [(0.1)](/filings/0001104659-25-106839.md) | [(1.3) d](/filings/0001104659-26-020650.md) | [(12.5)](/filings/0001104659-26-058558.md) | [12.3](/filings/0001104659-26-091124.md) | [11.7](/filings/0001104659-25-106839.md) | [(12.3) d](/filings/0001104659-26-020650.md) | [(10.2)](/filings/0001104659-26-058558.md) | [(1.2)](/filings/0001104659-26-091124.md) |
| Net income | $m | [(6.0)](/filings/0001558370-24-014717.md) | [(32.4) d](/filings/0001104659-26-020650.md) | [(51.3)](/filings/0001558370-25-007293.md) | [29.1](/filings/0001558370-25-010754.md) | [10.0](/filings/0001104659-25-106839.md) | [(19.1) d](/filings/0001104659-26-020650.md) | [(41.4)](/filings/0001104659-26-058558.md) | [29.5](/filings/0001104659-26-091124.md) | [30.0](/filings/0001104659-25-106839.md) | [(41.4) d](/filings/0001104659-26-020650.md) | [(40.5)](/filings/0001104659-26-058558.md) | [(12.2)](/filings/0001104659-26-091124.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0001558370-24-014717.md) | not reported | [(0.83)](/filings/0001558370-25-007293.md) | [0.46](/filings/0001558370-25-010754.md) | [0.16](/filings/0001104659-25-106839.md) | not reported | [(0.66)](/filings/0001104659-26-058558.md) | [0.46](/filings/0001104659-26-091124.md) | [0.47](/filings/0001104659-25-106839.md) | not reported | [(0.63)](/filings/0001104659-26-058558.md) | [(0.19)](/filings/0001104659-26-091124.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0001558370-24-014717.md) | not reported | [(0.83)](/filings/0001558370-25-007293.md) | [0.47](/filings/0001558370-25-010754.md) | [0.16](/filings/0001104659-25-106839.md) | not reported | [(0.66)](/filings/0001104659-26-058558.md) | [0.47](/filings/0001104659-26-091124.md) | [0.48](/filings/0001104659-25-106839.md) | not reported | [(0.63)](/filings/0001104659-26-058558.md) | [(0.19)](/filings/0001104659-26-091124.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [107](/filings/0001558370-23-017641.md) | [125](/filings/0001104659-26-020650.md) | [181](/filings/0001558370-24-007307.md) | [121](/filings/0001558370-24-011602.md) | [101](/filings/0001558370-24-014717.md) | [110](/filings/0001104659-26-020650.md) | [245](/filings/0001558370-25-007293.md) | [96.2](/filings/0001558370-25-010754.md) | [82.2](/filings/0001104659-25-106839.md) | [99.9](/filings/0001104659-26-091124.md) | [135](/filings/0001104659-26-058558.md) | [116](/filings/0001104659-26-091124.md) |
| Current assets | $m | [244](/filings/0001558370-23-017641.md) | [218](/filings/0001558370-25-002009.md) | [287](/filings/0001558370-24-007307.md) | [248](/filings/0001558370-24-011602.md) | [224](/filings/0001558370-24-014717.md) | [179](/filings/0001104659-26-020650.md) | [321](/filings/0001558370-25-007293.md) | [237](/filings/0001558370-25-010754.md) | [217](/filings/0001104659-25-106839.md) | [159](/filings/0001104659-26-091124.md) | [225](/filings/0001104659-26-058558.md) | [288](/filings/0001104659-26-091124.md) |
| Total assets | $m | [1,519](/filings/0001558370-23-017641.md) | [1,504](/filings/0001558370-25-002009.md) | [1,602](/filings/0001558370-24-007307.md) | [1,574](/filings/0001558370-24-011602.md) | [1,557](/filings/0001558370-24-014717.md) | [1,524](/filings/0001104659-26-020650.md) | [1,681](/filings/0001558370-25-007293.md) | [1,684](/filings/0001558370-25-010754.md) | [1,671](/filings/0001104659-25-106839.md) | [1,615](/filings/0001104659-26-091124.md) | [1,687](/filings/0001104659-26-058558.md) | [1,740](/filings/0001104659-26-091124.md) |
| Current liabilities | $m | [189](/filings/0001558370-23-017641.md) | [234](/filings/0001558370-25-002009.md) | [360](/filings/0001558370-24-007307.md) | [388](/filings/0001558370-24-011602.md) | [322](/filings/0001558370-24-014717.md) | [287](/filings/0001104659-26-020650.md) | [414](/filings/0001558370-25-007293.md) | [371](/filings/0001558370-25-010754.md) | [250](/filings/0001104659-25-106839.md) | [377](/filings/0001104659-26-091124.md) | [491](/filings/0001104659-26-058558.md) | [586](/filings/0001104659-26-091124.md) |
| Total liabilities | $m | [943](/filings/0001558370-23-017641.md) | [964](/filings/0001558370-25-002009.md) | [1,111](/filings/0001558370-24-007307.md) | [1,049](/filings/0001558370-24-011602.md) | [1,015](/filings/0001558370-24-014717.md) | [988](/filings/0001104659-26-020650.md) | [1,183](/filings/0001558370-25-007293.md) | [1,149](/filings/0001558370-25-010754.md) | [1,099](/filings/0001104659-25-106839.md) | [1,077](/filings/0001104659-26-091124.md) | [1,156](/filings/0001104659-26-058558.md) | [1,214](/filings/0001104659-26-091124.md) |
| Long-term debt | $m | [547](/filings/0001558370-23-017641.md) | [527](/filings/0001558370-25-002009.md) | [537](/filings/0001558370-24-007307.md) | [462](/filings/0001558370-24-011602.md) | [502](/filings/0001558370-24-014717.md) | [513](/filings/0001104659-26-020650.md) | [595](/filings/0001558370-25-007293.md) | [599](/filings/0001558370-25-010754.md) | [655](/filings/0001104659-25-106839.md) | [523](/filings/0001104659-26-091124.md) | [493](/filings/0001104659-26-058558.md) | [460](/filings/0001104659-26-091124.md) |
| Current portion of debt | $m | [7.8](/filings/0001558370-23-017641.md) | [42.2](/filings/0001558370-25-002009.md) | [42.5](/filings/0001558370-24-007307.md) | [138](/filings/0001558370-24-011602.md) | [138](/filings/0001558370-24-014717.md) | [104](/filings/0001104659-26-020650.md) | [104](/filings/0001558370-25-007293.md) | [104](/filings/0001558370-25-010754.md) | [105](/filings/0001104659-25-106839.md) | [215](/filings/0001104659-26-091124.md) | [216](/filings/0001104659-26-058558.md) | [333](/filings/0001104659-26-091124.md) |
| Shareholders' equity | $m | [564](/filings/0001558370-23-017641.md) | [529](/filings/0001558370-25-002009.md) | [479](/filings/0001558370-24-007307.md) | [513](/filings/0001558370-24-011602.md) | [530](/filings/0001558370-24-014717.md) | [524](/filings/0001104659-26-020650.md) | [486](/filings/0001558370-25-007293.md) | [523](/filings/0001558370-25-010754.md) | [560](/filings/0001104659-25-106839.md) | [526](/filings/0001104659-26-091124.md) | [519](/filings/0001104659-26-058558.md) | [514](/filings/0001104659-26-091124.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(57.2) d](/filings/0001558370-24-014717.md) | [22.9 d](/filings/0001104659-26-020650.md) | [91.1](/filings/0001558370-25-007293.md) | [(34.3) d](/filings/0001558370-25-010754.md) | [(69.0) d](/filings/0001104659-25-106839.md) | [28.9 d](/filings/0001104659-26-020650.md) | [95.8](/filings/0001104659-26-058558.md) | [(8.1) d](/filings/0001104659-26-091124.md) | [(88.8) d](/filings/0001104659-25-106839.md) | [26.4 d](/filings/0001104659-26-020650.md) | [62.5](/filings/0001104659-26-058558.md) | [(64.1) d](/filings/0001104659-26-091124.md) |
| Capital expenditure | $m | [15.6 d](/filings/0001558370-24-014717.md) | [23.7 d](/filings/0001558370-25-002009.md) | [27.6](/filings/0001558370-25-007293.md) | [29.8 d](/filings/0001558370-24-011602.md) | [16.5 d](/filings/0001558370-24-014717.md) | [12.1 d](/filings/0001558370-25-002009.md) | [19.5](/filings/0001558370-25-007293.md) | [74.2 d](/filings/0001104659-26-091124.md) | [0.0 d](/filings/0001104659-25-106839.md) | [0.0 d](/filings/0001104659-26-020650.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [62.6](/filings/0001558370-24-014717.md) | [62.7](/filings/0001558370-25-007293.md) | [62.8](/filings/0001558370-25-010754.md) | [63.0](/filings/0001104659-25-106839.md) | [63.3](/filings/0001104659-26-058558.md) | [63.5](/filings/0001104659-26-091124.md) | [63.8](/filings/0001104659-25-106839.md) | [64.4](/filings/0001104659-26-058558.md) | [65.0](/filings/0001104659-26-091124.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.